Virginia Borges, M.D., MMSc (IMAGE) University of Colorado Anschutz Medical Campus Caption Virginia Borges, M.D., MMSc, and colleagues report promising phase 1b results for tucatinib and T-DM1 against HER2+ breast cancer. Credit University of Colorado Cancer Center Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.